Copyright © 1995 by the European Society of Cardiology.
© 1995 The European Society of Cardiology
Cardiac manifestations in mid-gut carcinoid disease
Medical Departments A and B, Rikshospitalet, University of Oslo Norway
Received 21 March 1994; revised 18 July 1994; accepted 10 August 1994.
Correspondence: Morten Bj. Jacobsen MD, Medical Dept A, Rikshopitalet, N-0027 Oslo, Norway.
Abstract
The extent of heart disease and its relationship to the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), was studied with M-mode, 2D and Doppler echocardiography in 42 consecutive patients, 30 females and 12 males, median age 63 (range 2375) years with histologically verified mid-gut tumour, liver metastases and 24-h urinary 5-HIAA excretion above 47 µmol. 24h1.
All patients had normal left ventricular ejection fractions, median 65% (interquartile range (IQR) 5474%). Moderate to severe tricuspid regurgitation (TR) was diagnosed in 22 patients (59%); mitral or aortic regurgitation was found in nine (24%) and six (16%) patients, respectively. The mitral flow peak early (E) on late (A) velocity ratio was significantly decreased compared to age-matched normal subjects. The group of patients with 5-HIAA excretion exceeding 1000µmol. 24h1 contained significantly more patients with severe TR than those with a lower excretion.
The decrease in the El A ratio may indicate reduced left ventricular compliance, possibly secondary to fibrous changes similar to those seen intra-abdominally and in the right side of the heart. As serotonin is degraded in the lung circulation, other mediators such as tachykinins and cytokines (PDGF) may be involved.
Key Words: Carcinoid tumours diastolic function left ventricular filling myocardial fibrosis serotonin valvular heart disease
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Holdcroft Hormones and the gut Br. J. Anaesth., July 1, 2000; 85(1): 58 - 68. [Full Text] [PDF] |
||||
![]() |
P. Egermayer, G I. Town, and A. J Peacock Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension Thorax, February 1, 1999; 54(2): 161 - 168. [Full Text] |
||||

